Hindustan Bio Sciences Q2 Profit Reaches Rs 31 Lakh

Revenue rose to Rs 85.04 lakh in Q2 FY2027 from zero in the preceding quarter. Net profit reached Rs 31.04 lakh against a loss of Rs 11.29 lakh in the June quarter.

Reader Takeaway: The company has shifted to profit on the back of revenue growth, though maintaining this momentum remains critical.

What just happened

Hindustan Bio Sciences released its unaudited standalone financial results for the quarter ended September 30, 2026. The firm posted a profit of Rs 31.04 lakh, a notable recovery compared to the Rs 11.29 lakh loss reported for the quarter ended June 30, 2026. Revenue from operations climbed to Rs 82.21 lakh, signaling a return to commercial activity after a nil-revenue performance in the previous quarter.

Why this matters

For investors, the primary concern remains consistency. While the current quarter shows a positive bottom line, the company has historically experienced volatile performance. The total revenue for the period stood at Rs 85.04 lakh, supported by a controlled cost base of Rs 65.30 lakh, primarily tied to material consumption.

Governance Update

The company also disclosed that Mr. Shailendra Vyas will step down as Company Secretary and Compliance Officer, effective October 31, 2026. Management attributed this departure to his decision to pursue other career interests. This is considered a routine administrative change and is not expected to disrupt ongoing operations.

What to track next

Shareholders should monitor the appointment of a new Company Secretary to ensure leadership stability. Furthermore, investors will look for sustained revenue generation in the coming quarters to validate that the current profit is not a one-off event.